References
- Schow D A, Redmon B, Pryor JL. Male menopause. Postgrad Med 1997; 101: 62–79
- Vermeulen A. The male climacterium. Ann Med 1993; 25: 531–4
- Morley J E, Kaiser F E, Sih R, Hajjar R, Perry HM. Testosterone and frailty. Clin Geriatr Med 1997; 13: 685–95
- Tenover JS. Androgen administration to aging men. Endocrinol Metab Clin North Am 1994; 23: 877–92
- Winters SJ. Endocrine evaluation function. Endocrinol Metab Clin North Am 1994; 23: 709–23
- Tremblay R R, Dube J Y. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 1974; 10: 599–605
- Cumming D C, Wale SR. Non-sex hormone-binding globulin-bound testosterone as a marker of hyperandrogenism. J Clin Endocrinol Metab 1985; 61: 873–6
- Déchaud H, Lejeune H, Garosclo-Cholet M, Mallein R, Pugeat M. Radioimmunoassay of testosterone not bound to sex-steroid-binding protein in plasma. Clin Chem 1989; 35: 1609–14
- Nahoul K, Rayer M. Age-related decline of plasma bioavailable testosterone in adult men. J Steroid Biochem 1990; 35: 293–9
- Nankin H R, Calkins JH. Decreased bioavailable testosterone in aging and impotent men. J Clin Endocrinol Metab 1986; 63: 1418–20
- Tenover J S, Matsumoto A M, Plymate S R, Bremner WJ. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J Clin Endocrinol Metab 1987; 65: 1118–25
- Ferrini R L, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998; 147: 750–4
- Gray A, Feldman H A, McKinlay J B, Longcope C. Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73: 1016–25
- Baker H W, Burger H G, de Krester DM. Changes in the pituitary-testicular system with age. Clin Endocrinol 1976; 5: 349–72
- Pirke K M, Doerr P. Age related changes and inter-relationships between plasma testosterone, oestradiol, and testosterone-binding globulin in normal adult males. Acta Endocrinol (Copenh) 1973; 74: 792–800
- Stembach H. Age-associated testosterone decline in men: clinical issues for psychiatry. Am J Psychiatr 1998; 155: 1310–18
- Tenover JL. Testosterone and the aging male. J Androl 1997; 18: 103–6
- Tremblay R R, Morales A. Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency. The Aging Male 1998; 1: 213–18
- Purifoy F E, Roopmans L H, Mayes DM. Age differences in serum androgen levels in normal adult males. Hum Biol 1981; 53: 499–511
- Burns-Cox N, Gingell C. The andropause: fact or fiction. Postgrad Med J 1997; 73: 553–6
- Tsitouras P D, Bulat T. The aging male reproductive system. Endocrinol Metab Clin North Am 1995; 24: 297–315
- Matsumoto AM. Hormonal therapy of male hypogonadism. Endocrinol Metab Clin North Am 1994; 23: 857–75
- Ettinger B, Pressman A, Sklarin P, Bauer D C, Cauley J A, Cummings SR. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab 1998; 83: 2239–43
- Manni A, Pardridge W M, Cefalu W, Nisula B C, Wayne Bardin C, Santner S J, et al. Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab 1985; 61: 705–10
- Korenman SG. A pragmatic approach to androgen replacement in older men: risks versus benefits. J Clin Endocrinol Metab 1998; 83: 3435–48, Bhasin, S Bagatell, C J Bremner W J Plymate S R Tenover J L Korenman SG et al Issues in testosterone replacement in older men. Therapeutic Perspectives